On these premises, we investigated whether the upregulation of VDAC1, following a neonatal intraspinal injection of an adeno-associated virus (AAV), could counteract the mitochondrial dysfunction typical of ALS. The gene discussed is VDAC1; the disease is amyotrophic lateral sclerosis.